US-based wellness and healthcare services provider Alphaeon closed a series B round on Friday reported by Fortune to be sized at $70m, and which included diversified conglomerate Chow Tai Fook Enterprises.
The round was led by Sailing Capital, a growth equity fund set up by China state-owned financial holding entity Shanghai International Group, and also featured venture capital firms H&S Ventures and Longitude Capital.
Founded in 2012, Alphaeon operates a network of certified medical professionals who create personalised, proactive healthcare programs. The company offers services such as vision correction, and sells products such as omega-3 supplements.
Aphaeon has not revealed how it plans to invest the money. It raised $27m in a January 2015 series A round led by Longitude Capital.